{"entity":{"type":"insider","cik":"0001808905","url":"/insider/0001808905","json_url":"/insider/0001808905.json","name":"ADAMS R MARK","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":13,"first":"2021-04-09","last":"2023-04-12","span_basis":"filed_date"},"name_variants":[{"name":"ADAMS R MARK","source":"filing","n_filings":13,"first_seen":"2021-04-09","last_seen":"2023-04-12"}],"transactions":[{"id":8066724,"accession":"0001062993-23-009085","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-009085","line_url":"/filing/0001062993-23-009085#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001808905","owner_name":"ADAMS R MARK","owner_display_name":"ADAMS R MARK","owner_url":"/insider/0001808905","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2308.0,"shares_display":"2,308","price_per_share":8.63,"price_display":"8.63","price_state":"stated","total_value":19918.04,"total_display":"19,918.04","total_whole":"19,918","shares_owned_after":175361.0,"shares_owned_after_display":"175,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-11","filed_date":"2023-04-12","scope":"insider"},{"id":8066720,"accession":"0001062993-23-009085","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-23-009085","line_url":"/filing/0001062993-23-009085#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001808905","owner_name":"ADAMS R MARK","owner_display_name":"ADAMS R MARK","owner_url":"/insider/0001808905","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":817.0,"shares_display":"817","price_per_share":8.5,"price_display":"8.50","price_state":"stated","total_value":6944.5,"total_display":"6,944.50","total_whole":"6,945","shares_owned_after":177669.0,"shares_owned_after_display":"177,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-10","filed_date":"2023-04-12","scope":"insider"},{"id":8283632,"accession":"0001062993-23-006327","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-23-006327","line_url":"/filing/0001062993-23-006327#line-3","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001808905","owner_name":"ADAMS R MARK","owner_display_name":"ADAMS R MARK","owner_url":"/insider/0001808905","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17155.0,"shares_display":"17,155","price_per_share":8.6,"price_display":"8.60","price_state":"stated","total_value":147533.0,"total_display":"147,533.00","total_whole":"147,533","shares_owned_after":178486.0,"shares_owned_after_display":"178,486","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-07","filed_date":"2023-03-08","scope":"insider"},{"id":8283629,"accession":"0001062993-23-006327","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-006327","line_url":"/filing/0001062993-23-006327#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001808905","owner_name":"ADAMS R MARK","owner_display_name":"ADAMS R MARK","owner_url":"/insider/0001808905","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6529.0,"shares_display":"6,529","price_per_share":8.57,"price_display":"8.57","price_state":"stated","total_value":55953.53,"total_display":"55,953.53","total_whole":"55,954","shares_owned_after":195641.0,"shares_owned_after_display":"195,641","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-06","filed_date":"2023-03-08","scope":"insider"},{"id":8287265,"accession":"0001209191-23-003052","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-003052","line_url":"/filing/0001209191-23-003052#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001808905","owner_name":"ADAMS R MARK","owner_display_name":"ADAMS R MARK","owner_url":"/insider/0001808905","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2130.0,"shares_display":"2,130","price_per_share":8.58,"price_display":"8.58","price_state":"stated","total_value":18275.4,"total_display":"18,275.40","total_whole":"18,275","shares_owned_after":113518.0,"shares_owned_after_display":"113,518","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-10","filed_date":"2023-01-11","scope":"insider"},{"id":8287261,"accession":"0001209191-23-003052","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-003052","line_url":"/filing/0001209191-23-003052#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001808905","owner_name":"ADAMS R MARK","owner_display_name":"ADAMS R MARK","owner_url":"/insider/0001808905","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":995.0,"shares_display":"995","price_per_share":8.5,"price_display":"8.50","price_state":"stated","total_value":8457.5,"total_display":"8,457.50","total_whole":"8,458","shares_owned_after":115648.0,"shares_owned_after_display":"115,648","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2023-01-11","scope":"insider"},{"id":6632052,"accession":"0001209191-22-053372","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-053372","line_url":"/filing/0001209191-22-053372#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001808905","owner_name":"ADAMS R MARK","owner_display_name":"ADAMS R MARK","owner_url":"/insider/0001808905","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2284.0,"shares_display":"2,284","price_per_share":7.13,"price_display":"7.13","price_state":"stated","total_value":16284.92,"total_display":"16,284.92","total_whole":"16,285","shares_owned_after":116643.0,"shares_owned_after_display":"116,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-10","filed_date":"2022-10-11","scope":"insider"},{"id":6632048,"accession":"0001209191-22-053372","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-053372","line_url":"/filing/0001209191-22-053372#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001808905","owner_name":"ADAMS R MARK","owner_display_name":"ADAMS R MARK","owner_url":"/insider/0001808905","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":841.0,"shares_display":"841","price_per_share":7.61,"price_display":"7.61","price_state":"stated","total_value":6400.01,"total_display":"6,400.01","total_whole":"6,400","shares_owned_after":118927.0,"shares_owned_after_display":"118,927","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-07","filed_date":"2022-10-11","scope":"insider"},{"id":6251944,"accession":"0001209191-22-041730","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-041730","line_url":"/filing/0001209191-22-041730#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001808905","owner_name":"ADAMS R MARK","owner_display_name":"ADAMS R MARK","owner_url":"/insider/0001808905","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":10.47,"price_display":"10.47","price_state":"stated","total_value":24081.0,"total_display":"24,081.00","total_whole":"24,081","shares_owned_after":119768.0,"shares_owned_after_display":"119,768","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-08","filed_date":"2022-07-08","scope":"insider"},{"id":6251941,"accession":"0001209191-22-041730","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-041730","line_url":"/filing/0001209191-22-041730#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001808905","owner_name":"ADAMS R MARK","owner_display_name":"ADAMS R MARK","owner_url":"/insider/0001808905","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":825.0,"shares_display":"825","price_per_share":9.53,"price_display":"9.53","price_state":"stated","total_value":7862.25,"total_display":"7,862.25","total_whole":"7,862","shares_owned_after":122068.0,"shares_owned_after_display":"122,068","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-07","filed_date":"2022-07-08","scope":"insider"},{"id":6846665,"accession":"0001209191-22-023916","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-023916","line_url":"/filing/0001209191-22-023916#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001808905","owner_name":"ADAMS R MARK","owner_display_name":"ADAMS R MARK","owner_url":"/insider/0001808905","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":831.0,"shares_display":"831","price_per_share":13.17,"price_display":"13.17","price_state":"stated","total_value":10944.27,"total_display":"10,944.27","total_whole":"10,944","shares_owned_after":122893.0,"shares_owned_after_display":"122,893","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-07","filed_date":"2022-04-08","scope":"insider"},{"id":6778322,"accession":"0001209191-22-017392","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-017392","line_url":"/filing/0001209191-22-017392#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001808905","owner_name":"ADAMS R MARK","owner_display_name":"ADAMS R MARK","owner_url":"/insider/0001808905","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1244.0,"shares_display":"1,244","price_per_share":12.01,"price_display":"12.01","price_state":"stated","total_value":14940.44,"total_display":"14,940.44","total_whole":"14,940","shares_owned_after":123724.0,"shares_owned_after_display":"123,724","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-07","filed_date":"2022-03-08","scope":"insider"},{"id":6202840,"accession":"0001209191-22-002766","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-002766","line_url":"/filing/0001209191-22-002766#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001808905","owner_name":"ADAMS R MARK","owner_display_name":"ADAMS R MARK","owner_url":"/insider/0001808905","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1021.0,"shares_display":"1,021","price_per_share":23.32,"price_display":"23.32","price_state":"stated","total_value":23809.72,"total_display":"23,809.72","total_whole":"23,810","shares_owned_after":50833.0,"shares_owned_after_display":"50,833","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-07","filed_date":"2022-01-10","scope":"insider"},{"id":4236948,"accession":"0001209191-21-060116","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-060116","line_url":"/filing/0001209191-21-060116#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001808905","owner_name":"ADAMS R MARK","owner_display_name":"ADAMS R MARK","owner_url":"/insider/0001808905","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1801.0,"shares_display":"1,801","price_per_share":33.67,"price_display":"33.67","price_state":"stated","total_value":60639.67,"total_display":"60,639.67","total_whole":"60,640","shares_owned_after":51854.0,"shares_owned_after_display":"51,854","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-08","filed_date":"2021-10-08","scope":"insider"},{"id":4236942,"accession":"0001209191-21-060116","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-060116","line_url":"/filing/0001209191-21-060116#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001808905","owner_name":"ADAMS R MARK","owner_display_name":"ADAMS R MARK","owner_url":"/insider/0001808905","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1324.0,"shares_display":"1,324","price_per_share":32.47,"price_display":"32.47","price_state":"stated","total_value":42990.28,"total_display":"42,990.28","total_whole":"42,990","shares_owned_after":53655.0,"shares_owned_after_display":"53,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-07","filed_date":"2021-10-08","scope":"insider"},{"id":4537134,"accession":"0001209191-21-046083","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-046083","line_url":"/filing/0001209191-21-046083#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001808905","owner_name":"ADAMS R MARK","owner_display_name":"ADAMS R MARK","owner_url":"/insider/0001808905","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2254.0,"shares_display":"2,254","price_per_share":36.3,"price_display":"36.30","price_state":"stated","total_value":81820.2,"total_display":"81,820.20","total_whole":"81,820","shares_owned_after":54979.0,"shares_owned_after_display":"54,979","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-08","filed_date":"2021-07-08","scope":"insider"},{"id":4537128,"accession":"0001209191-21-046083","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-046083","line_url":"/filing/0001209191-21-046083#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001808905","owner_name":"ADAMS R MARK","owner_display_name":"ADAMS R MARK","owner_url":"/insider/0001808905","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":871.0,"shares_display":"871","price_per_share":39.42,"price_display":"39.42","price_state":"stated","total_value":34334.82,"total_display":"34,334.82","total_whole":"34,335","shares_owned_after":57233.0,"shares_owned_after_display":"57,233","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-07","filed_date":"2021-07-08","scope":"insider"},{"id":4938422,"accession":"0001209191-21-042290","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-042290","line_url":"/filing/0001209191-21-042290#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001808905","owner_name":"ADAMS R MARK","owner_display_name":"ADAMS R MARK","owner_url":"/insider/0001808905","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14583.0,"shares_display":"14,583","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":583320.0,"total_display":"583,320.00","total_whole":"583,320","shares_owned_after":58104.0,"shares_owned_after_display":"58,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-17","filed_date":"2021-06-21","scope":"insider"},{"id":5334207,"accession":"0001209191-21-041088","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-041088","line_url":"/filing/0001209191-21-041088#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001808905","owner_name":"ADAMS R MARK","owner_display_name":"ADAMS R MARK","owner_url":"/insider/0001808905","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8914.0,"shares_display":"8,914","price_per_share":38.77,"price_display":"38.77","price_state":"stated","total_value":345595.78,"total_display":"345,595.78","total_whole":"345,596","shares_owned_after":58104.0,"shares_owned_after_display":"58,104","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-14","filed_date":"2021-06-16","scope":"insider"},{"id":5521796,"accession":"0001209191-21-026200","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-026200","line_url":"/filing/0001209191-21-026200#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001808905","owner_name":"ADAMS R MARK","owner_display_name":"ADAMS R MARK","owner_url":"/insider/0001808905","role":"Officer (Chief Operating Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operating Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operating Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3586.0,"shares_display":"3,586","price_per_share":42.34,"price_display":"42.34","price_state":"stated","total_value":151831.24,"total_display":"151,831.24","total_whole":"151,831","shares_owned_after":67018.0,"shares_owned_after_display":"67,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-07","filed_date":"2021-04-09","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001478320","name":"Adaptive Biotechnologies Corp","url":"/issuer/0001478320","role":"Officer (Chief Operating Officer)","n_filings":13,"first_seen":"2021-04-09","last_seen":"2023-04-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001808905","retrieved_at":"2026-08-22T15:52:45+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}